Latest Roche Stories

2011-05-16 00:30:00

LEUVEN, Belgium and LUND, Sweden, May 16, 2011 /PRNewswire-FirstCall/ -- - Two New Studies Now Ongoing: Phase Ib/II in Patients With Aggressive Brain Tumour and Phase Ib in Primary Liver Cancer ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International AB (OMXS: BINV) announce today that their partner Roche (SIX: RO, ROG; OTCQX: RHHBY) has dosed the first patient in a Phase Ib/II study with the novel antibody anti-cancer agent TB-403 (RG7334).

2011-05-05 08:00:00

NUTLEY, N.J., May 5, 2011 /PRNewswire/ -- Susan Graf, of Nutley, N.J., Global Head of Strategic Evaluation and Due Diligence in Roche Partnering, was honored as a 2011 Rising Star by the Healthcare Businesswomen's Association (HBA) at the organization's annual awards luncheon today in New York City.

2011-05-05 08:00:00

NUTLEY, N.J., May 5, 2011 /PRNewswire/ -- Two Roche employees are being recognized for their significant contributions to industry in New Jersey at the 37th Annual TWIN Awards Dinner held May 5, 2011.

2011-04-25 05:45:00

PRINCETON, N.J., April 25, 2011 /PRNewswire/ -- Pharmasset, Inc.

2011-04-08 21:47:00

ATLANTIC CITY, N.J., April 8, 2011 /PRNewswire/ -- Hagens Berman LLP, a nationally recognized law firm today praised a jury's verdict that ordered pharmaceutical company Roche (ROG:VX) to pay $2 million to a woman who suffered serious gastrointestinal damage caused by the drug Accutane, while denying similar claims of actor James Marshall and another plaintiff.

2011-03-28 08:05:00

NUTLEY, N.J., March 28, 2011 /PRNewswire/ -- Roche announced today that Janet Hammond, MD, Ph.D., has joined the company as Vice President, Translational Medicine - Virology in Pharmaceutical Research and Early Development (pRED).

2011-03-22 07:00:00

MADISON, Wis., March 22, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's iCell® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of developing drug candidates was completed early and is now transitioning into a standard supply agreement.

2011-02-23 10:18:00

INDIANAPOLIS and FORT BRAGG, N.C., Feb. 23, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S.

2011-02-16 00:00:00

SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc.

Word of the Day
  • Emitting flashes of light; glittering.
The word 'coruscant' comes from a Latin word meaning 'to flash' or 'to sparkle'.